Vanguard Group Inc. cut its stake in Dentsply International Inc. (NASDAQ:XRAY) by 0.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,105,204 shares of the company’s stock after selling 191,910 shares during the period. Vanguard Group Inc. owned about 9.03% of Dentsply International worth $1,309,367,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in XRAY. State Street Corp boosted its stake in Dentsply International by 58.3% in the first quarter. State Street Corp now owns 10,034,613 shares of the company’s stock valued at $618,429,000 after buying an additional 3,696,056 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its stake in Dentsply International by 71.9% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 6,691,695 shares of the company’s stock valued at $412,409,000 after buying an additional 2,798,549 shares during the last quarter. Neuberger Berman Group LLC boosted its stake in Dentsply International by 6.2% in the second quarter. Neuberger Berman Group LLC now owns 6,653,874 shares of the company’s stock valued at $412,806,000 after buying an additional 390,062 shares during the last quarter. Jackson Square Partners LLC boosted its stake in Dentsply International by 95.8% in the first quarter. Jackson Square Partners LLC now owns 6,300,098 shares of the company’s stock valued at $388,275,000 after buying an additional 3,082,688 shares during the last quarter. Finally, Veritas Asset Management LLP boosted its stake in Dentsply International by 0.5% in the second quarter. Veritas Asset Management LLP now owns 5,322,706 shares of the company’s stock valued at $330,221,000 after buying an additional 24,624 shares during the last quarter. 94.43% of the stock is owned by hedge funds and other institutional investors.

Shares of Dentsply International Inc. (NASDAQ:XRAY) traded up 0.77% during trading on Monday, reaching $60.09. 81,536 shares of the company’s stock were exchanged. The company has a 50 day moving average of $61.50 and a 200 day moving average of $61.62. Dentsply International Inc. has a 52-week low of $49.48 and a 52-week high of $65.83. The firm has a market capitalization of $14.00 billion, a P/E ratio of 28.20 and a beta of 1.40.

Dentsply International (NASDAQ:XRAY) last released its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.70 by $0.06. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The company’s revenue for the quarter was up 46.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.73 EPS. Equities analysts anticipate that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.

Several analysts have commented on XRAY shares. Credit Suisse Group AG reaffirmed a “buy” rating on shares of Dentsply International in a research note on Sunday, June 5th. Zacks Investment Research cut shares of Dentsply International from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Jefferies Group reissued a “buy” rating on shares of Dentsply International in a research note on Wednesday, August 17th. Barrington Research cut shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research note on Monday, August 8th. Finally, Bank of America Corp. initiated coverage on shares of Dentsply International in a research note on Monday, September 12th. They set a “buy” rating and a $70.00 price objective for the company. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Dentsply International presently has a consensus rating of “Buy” and a consensus target price of $67.00.

In other news, VP Rainer Berthan sold 5,000 shares of the stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total transaction of $305,600.00. Following the transaction, the vice president now owns 34,370 shares in the company, valued at approximately $2,100,694.40. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Maureen J. Macinnis sold 45,100 shares of the stock in a transaction on Thursday, August 25th. The stock was sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the transaction, the senior vice president now owns 36,730 shares in the company, valued at approximately $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.